What is BioSig Technologies, Inc.'s working captal deficit?

BioSig Technologies, Inc. (STEX) reported working captal deficit of $42.6M in Q1 2026.

What does working captal deficit mean?

Represents the shortfall where current liabilities exceed current assets, indicating a potential strain on short-term operational funding. This metric highlights the company's reliance on external financing or cash flow generation to cover immediate obligations. A persistent deficit may signal liquidity risks that require management attention.

BioSig Technologies, Inc. STEX Working Captal Deficit

Working Captal Deficit at other companies

NextNRG, Inc. Common StockNXXT

$25M+4.0%

PCS

Perceptive Capital SolutionsPCSC

$2.21M+105%

NMP

Nuveen Prem Inc Muni FundNMP

$51.91K—

IRA

Iris Acquisition IRAB

$788.45K—

ORI

Origin Investment Corp I Ordinary SharesORIQ

$844.33K—

Blink Charging Co.BLNK

$14.21M-78.4%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept STEX:WorkingCaptalDeficit.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s working captal deficit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s working captal deficit?: BioSig Technologies, Inc. (STEX) reported working captal deficit of $42.6M in Q1 2026.
What does working captal deficit mean?: Represents the shortfall where current liabilities exceed current assets, indicating a potential strain on short-term operational funding. This metric highlights the company's reliance on external financing or cash flow generation to cover immediate obligations. A persistent deficit may signal liquidity risks that require management attention.